Log in

Relevant bibliographies by topics / Geriatric psychiatry New Zealand / Journal articles

Journal articles on the topic 'Geriatric psychiatry New Zealand'

To see the other types of publications on this topic, follow the link: Geriatric psychiatry New Zealand.

Author: Grafiati

Published: 10 December 2022

Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Geriatric psychiatry New Zealand.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Mitchell, Terry, Michael Woodward, and Yuichi Hirose. "A survey of attitudes of clinicians towards the diagnosis and treatment of mild cognitive impairment in Australia and New Zealand." International Psychogeriatrics 20, no. 1 (February 2008): 77–85. http://dx.doi.org/10.1017/s1041610207005583.

Full text

Abstract:

ABSTRACTObjectives: The aim of the study was to assess the attitudes of clinicians to the diagnostic construct of mild cognitive impairment (MCI), their approach to relaying the diagnosis to patients and families, and recommended treatment and follow-up.Method: An anonymous questionnaire was sent out to 503 members of the Australian Society for Geriatric Medicine (ASGM) and New Zealand Geriatrics Society (NZGS), of whom 163 replied.Results: Most responders (83%) had diagnosed MCI. About 70% rated the importance of separating MCI from dementia, or MCI from normal cognition, as 4 or 5 on a scale from 1 (not very important) to 5 (very important). Most responders reported that they would inform their patients and families of a diagnosis of MCI, and used that term. A minority used the term “early Alzheimer's disease,” but 44% of NZGS members used other terms to relay the diagnosis compared to 13% of ASGM members. Follow-up was most often recommended at 6–12 months. Non-pharmacological treatment (such as mental stimulation strategies) was recommended most often, followed by no treatment.Conclusions: The diagnostic entity of MCI appears to have a general acceptance among those who responded to the survey, and the term has gained use in clinical practice. Most clinicians are recommending follow-up, recognizing the high risk for progression. Treatment recommendations do not favor pharmaceuticals, reflecting the current evidence for lack of effect.

APA, Harvard, Vancouver, ISO, and other styles

2

NG, Bradley. "The role of psychostimulants in psychogeriatrics: a New Zealand survey." Psychogeriatrics 9, no. 3 (September 2009): 121–26. http://dx.doi.org/10.1111/j.1479-8301.2009.00295.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hall, Yvette, Philippa Greco, Kenny Hau, and Yoram Barak. "Older adults abuse: analysis of a New Zealand national dataset." International Psychogeriatrics 32, no. 8 (August 2020): 1003–8. http://dx.doi.org/10.1017/s1041610220001520.

Full text

Abstract:

ABSTRACTOlder adult abuse (OAA), defined as abuse, neglect, or mistreatment of persons aged 65 years or older, is a globally pervasive concern, with severe consequences for its victims. While internationally reported rates of OAA are in the range of 5–20% per annum, New Zealand lacks the necessary data to quantify the issue. However, with a growing aging population, an increase in the prevalence of OAA is predicted. We investigated the extent of OAA in New Zealand, utilizing the mandatory interRAI-HC (International Resident Assessment Instrument-home care assessment) dataset, which included 18,884 interviewees from the Southern District Health Board between 2013 and 2019. Findings confirmed our hypothesis that the interRAI assessment is neither sufficiently sensitive nor specific capturing only 3% from a population of increased frailty and thus at higher risk of abuse. We characterized OAA victims as relatively younger males, depressed, and with impaired decision-making capacity. If the interRAIs were to serve as a preliminary screening tool for OAA in New Zealand, it would be germane to implement changes to improve its detection rate. Further studies are urgently called for to test changes in the interRAI that will aid in identifying often missed cases of OAA better and thus offer protection to this vulnerable population.

APA, Harvard, Vancouver, ISO, and other styles

4

Abbott, Max W., Max W. Abbott, Sai Wong, Lynne C. Giles, Sue Wong, Wilson Young, and Ming Au. "Depression in Older Chinese Migrants to Auckland." Australian & New Zealand Journal of Psychiatry 37, no. 4 (August 2003): 445–51. http://dx.doi.org/10.1046/j.1440-1614.2003.01212.x.

Full text

Abstract:

Objective: This study was conducted to identify risk factors for depressive symptomatology among older Chinese migrants. Method: One hundred and sixty-two Chinese migrants aged 55 years or older, living in the community and recruited via Chinese community organizations and general practitioners, were interviewed using a Chinese version of the Geriatric Depression Scale and measures of stressful life events, morbid conditions, self-rated health, acculturation, social support and service utilization. Result: Twenty-six percent of participants met the criteria for depressive symptomatology. No recent migrants showed symptoms of depression. Multiple logistic regression analysis showed that lower emotional support, greater number of visits to a doctor, difficulties in accessing health services and low New Zealand cultural orientation increased the risk of showing symptoms of depression. Conclusion: Significant numbers of older Chinese migrants appear to be depressed or at risk for depression and, while participants with depressive symptoms consulted general practitioners more than their counterparts without such symptoms, they reported greater difficulty in accessing health services. The findings point to the need for further epidemiological study of this growing sector of the population and investigation of the nature of its engagement with health services. Social support and aspects of acculturation may play a significant role in preventing depression. This also requires further investigation.

APA, Harvard, Vancouver, ISO, and other styles

5

Draper, Brian, and Dave Anderson. "The baby boomers are nearly here – but do we have sufficient workforce in old age psychiatry?" International Psychogeriatrics 22, no. 6 (June 3, 2010): 947–49. http://dx.doi.org/10.1017/s1041610210000566.

Full text

Abstract:

In 2011, the baby boomer generation officially commences its residency in the 65 years and over age group (U.S. Census Bureau, 2006). The much anticipated rapid growth in the population aged 65 years and over between 2011 and 2030 will challenge health care systems worldwide. Mental health services for older people will need to prepare for a near doubling of possible demand based upon estimates of the increase in prevalence of mental disorders in late life in this period in the developed world, with the increase likely to be greater in low and middle income countries (Bartels, 2003; Alzheimer's Disease International, 2009). The pressures that this will place upon the old age psychiatry workforce has contributed to the impetus for the Faculties of Psychiatry of Old Age of the Royal College of Psychiatrists and the Royal Australian and New Zealand College of Psychiatrists to prepare a ‘Joint Statement on Specialist Old Age Psychiatry Workforce and Training’ (see Appendix).

APA, Harvard, Vancouver, ISO, and other styles

6

BUTLER, R., S. FONSEKA, L. BARCLAY, S. SEMBHI, and S. WELLS. "The mental health of nursing home residents: A New Zealand study." Aging & Mental Health 2, no. 1 (February 1, 1998): 49–52. http://dx.doi.org/10.1080/13607869856939.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Jordan, Jennifer, Marie Crowe, Deborah Gillon, Cate McCall, Christopher Frampton, and Hamish Jamieson. "Reduced Pain Reports With Increasing Cognitive Impairment in Older Persons in New Zealand." American Journal of Alzheimer's Disease & Other Dementiasr 33, no. 7 (May 1, 2018): 463–70. http://dx.doi.org/10.1177/1533317518772685.

Full text

Abstract:

Background: Conflicting findings prevail about pain in older persons with cognitive impairment. There is evidence of changed pain perception; however, pain is also underrecognized. Pain and cognitive impairment were examined in a national cohort of older persons assessed using the Home Care International Residential Assessment Instrument (interRAI-HC). Methods: Participants were 41 459 aged 65+ years receiving a mandated needs assessment to access publicly funded services. InterRAI-HC pain severity and Cognitive Performance Scale analyses covaried for age, gender, and ethnicity. Results: Milder pain prevalence increased with age, whereas daily severe-excruciating pain prevalence decreased with age. Daily severe-excruciating pain was reported by 18% of cognitively intact individuals decreasing to 8% in the severe cognitive impairment group. This relationship remained after covarying for age, sex, and ethnicity. Differences among dementia subtypes were found. Conclusion: Although severe pain reports decrease with increasing age and cognitive impairment, more nuanced research covarying for dementia severity and subtype is required.

APA, Harvard, Vancouver, ISO, and other styles

8

Greve, Melissa, and Daniel O'Connor. "A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia (BPSD)." International Psychogeriatrics 17, no. 2 (June 2005): 195–205. http://dx.doi.org/10.1017/s1041610205001481.

Full text

Abstract:

Background: People with behavioral and psychological symptoms of dementia (BPSD) are often prescribed psychotropic medications. There is little evidence that one class of medication is more effective and safer than another and so expert opinion plays an important role in shaping local practice. In an earlier U.S. survey of psychiatrists and neurologists, limited consensus emerged regarding the pharmacological management of BPSD. We repeated this study to check consensus levels in Australia and New Zealand, following the introduction of newer atypical neuroleptics, antidepressants and cholinesterase inhibitors, and to identify areas where drug trials will be of greatest benefit.Methods: A brief structured survey, similar to one used in the U.S.A., was posted to a random sample of members of the Australian and New Zealand Faculty of Psychiatry of Old Age.Results: We received 106 replies (71% response). Respondents, who had 14 years' experience on average, rated atypical neuroleptics as their treatment of choice for dementia complicated by psychosis, verbal aggression, physical aggression, sundowning and persistent yelling. Opinions varied widely regarding the management of other symptoms and the role of second-line treatments.Conclusion: Atypical neuroleptics were preferred by most respondents for treatment of most BPSD. These views, while based on considerable clinical experience, have only limited backing from published reports, and head-to-head studies of available treatments are required to ensure that clinical practice has scientific support.

APA, Harvard, Vancouver, ISO, and other styles

9

Bronwyn, Copeland, Cheryl Collier, and Jessica Braim. "531 - Dementia prevention and utilising the “teachable moment” in the New Zealand context." International Psychogeriatrics 33, S1 (October 2021): 76. http://dx.doi.org/10.1017/s104161022100226x.

Full text

Abstract:

Dementia is a debilitating disease with wide-reaching impacts. Up to 40% of dementias are estimated to be preventable through modifiable risk factors, which is essential as no disease-modifying treatments are currently available. A literature review was performed using the OVID database, Google Scholar, and following references. Dementia as a key word was combined with the following key words: education, prevention, risk reduction, risk perception, family members, adult children, health promotion, behaviour change, Maori Health, health literacy, healthy aging, behavioural intervention, attitudes, teachable moment, psychoeducation.

APA, Harvard, Vancouver, ISO, and other styles

10

Russ, Tom C., Laura Murianni, Gloria Icaza, Andrea Slachevsky, and John M. Starr. "Geographical Variation in Dementia Mortality in Italy, New Zealand, and Chile: The Impact of Latitude, Vitamin D, and Air Pollution." Dementia and Geriatric Cognitive Disorders 42, no. 1-2 (2016): 31–41. http://dx.doi.org/10.1159/000447449.

Full text

Abstract:

Background: Dementia risk is reported as being higher in the north compared to the south, which may be related to vitamin D deficiency. If this were the case, an opposite gradient of risk would be observed in the southern hemisphere, but this has not been investigated previously. Methods: We calculated standardised mortality ratios (SMRs) for deaths in 2012 where dementia (Alzheimer's disease, vascular or unspecified dementia) was recorded as the underlying cause for 20 regions in Italy, 20 District Health Board areas in New Zealand and 29 Health Service areas in Chile. Results: Dementia SMRs were higher in northern than central or southern Italy. The inverse pattern was seen in women in New Zealand, with rates higher on South Island than North Island. However, dementia risk was raised in eight regions in the north and centre of Chile in both men and women. Conclusions: Geographical variation plays a key role in dementia risk, but patterns vary in men and women. In the northern hemisphere, dementia mortality is higher in the north, but the pattern in the southern hemisphere is more complex.

APA, Harvard, Vancouver, ISO, and other styles

11

Ibrikji, Sidonie E., and Shumei Man. "Attaining Health Equity in New Zealand and the World." Lancet Regional Health - Western Pacific 20 (March 2022): 100408. http://dx.doi.org/10.1016/j.lanwpc.2022.100408.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Wang, Joanna, Elsie Ho, Patrick Au, and Gary Cheung. "Late-life suicide in Asian people living in New Zealand: a qualitative study of coronial records." Psychogeriatrics 18, no. 4 (July 2018): 259–67. http://dx.doi.org/10.1111/psyg.12318.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Cheung, Gary, Kerry Appleton, Michal Boyd, and Sarah Cullum. "Perspectives of dementia from Asian communities living in New Zealand: A focus group of Asian health care professionals." International Journal of Geriatric Psychiatry 34, no. 12 (August 14, 2019): 1758–64. http://dx.doi.org/10.1002/gps.5189.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Dudley, Margaret Diana, Oliver Menzies, Suzanne Barker-Collo, Gary Cheung, Hinemoa Elder, and Ngaire Kerse. "A NEW ZEALAND INDIGENOUS APPROACH TO THE DIAGNOSIS AND MANAGEMENT OF DEMENTIA." Alzheimer's & Dementia 13, no. 7 (July 2017): P1205—P1206. http://dx.doi.org/10.1016/j.jalz.2017.06.1807.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Cullum, Sarah, Chris Varghese, Christin Coomarasamy, Rosie Whittington, Laura Hadfield, Aakash Rajay, Brian Yeom, et al. "Predictors of mortality in Māori, Pacific Island, and European patients diagnosed with dementia at a New Zealand Memory Service." International Journal of Geriatric Psychiatry 35, no. 5 (May 2020): 516–24. http://dx.doi.org/10.1002/gps.5266.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Crengle, Sue, Gabrielle Davie, Jesse Whitehead, Brandon de Graaf, Ross Lawrenson, and Garry Nixon. "Mortality outcomes and inequities experienced by rural Māori in Aotearoa New Zealand." Lancet Regional Health - Western Pacific 28 (November 2022): 100570. http://dx.doi.org/10.1016/j.lanwpc.2022.100570.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Dulin, Patrick L., Jhanitra Gavala, Christine Stephens, Marylynne Kostick, and Jennifer McDonald. "Volunteering predicts happiness among older Māori and non-Māori in the New Zealand health, work, and retirement longitudinal study." Aging & Mental Health 16, no. 5 (February 1, 2012): 617–24. http://dx.doi.org/10.1080/13607863.2011.641518.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Ahuriri-Driscoll, Annabel, Sarah Lovell, Deborah Te Kawa, Lindsey Te Ata o. Tū MacDonald, and Kaaren Mathias. "The future of Māori health is here – The 2022 Aotearoa New Zealand health reforms." Lancet Regional Health - Western Pacific 28 (November 2022): 100589. http://dx.doi.org/10.1016/j.lanwpc.2022.100589.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Andrew, D. H., and P. L. Dulin. "The relationship between self-reported health and mental health problems among older adults in New Zealand: Experiential avoidance as a moderator." Aging & Mental Health 11, no. 5 (September 2007): 596–603. http://dx.doi.org/10.1080/13607860601086587.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Martinez-Ruiz, Adrian, Ying Huang, Susan Gee, Hamish Jamieson, and Gary Cheung. "P2-299: INDIVIDUAL RISK FACTORS FOR POSSIBLE UNDETECTED DEMENTIA AMONGST COMMUNITY-DWELLING OLDER PEOPLE IN NEW ZEALAND." Alzheimer's & Dementia 14, no. 7S_Part_15 (July 1, 2006): P796—P797. http://dx.doi.org/10.1016/j.jalz.2018.06.988.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Silwal, Pushkar, Renata Watene, Matire Harwood, and Jacqueline Ramke. "Eye health for all in Aotearoa New Zealand: Summarising our situation using a WHO tool." Lancet Regional Health - Western Pacific 30 (January 2023): 100665. http://dx.doi.org/10.1016/j.lanwpc.2022.100665.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Boston, Ann F., and Paul L. Merrick. "Health anxiety among older people: an exploratory study of health anxiety and safety behaviors in a cohort of older adults in New Zealand." International Psychogeriatrics 22, no. 4 (February 4, 2010): 549–58. http://dx.doi.org/10.1017/s1041610209991712.

Full text

Abstract:

ABSTRACTBackground: Despite a stereotype that characterizes older people as excessively anxious about their health, there is little research into this phenomenon. The present exploratory study examined: (a) whether a cohort of older adults was unduly health anxious, (b) which demographic and health factors predicted health anxiety (HA), and (c) whether an aspect of the cognitive behavioral model of HA was applicable to older adults by investigating the relationship between HA and safety behaviors.Method: Participants were a convenience sample of adults aged over 65 and living independently in Auckland, New Zealand. Participants (104 women and 41 men) completed an anonymous self-report questionnaire measuring demographic factors, physical health and function, health anxiety, safety behaviors, and medical utilization.Results: This cohort of adults over 65 were not unduly health anxious. Occurrence of severe HA was similar to that found in younger populations. Decreased physical function and lower education predicted scores on the HA measure. Consistent with the cognitive behavioral model, HA was a unique significant predictor of safety behaviors. HA and decreased physical function predicted medical utilization.Conclusions: Generally low levels of HA among this cohort of older individuals challenged the pervasive stereotype of the “hypochondriacal” older person. Factors contributing to HA were similar to those reported in studies with younger cohorts. Findings provided preliminary support for the applicability of the cognitive behavioral model of HA to adults over 65. Implications of the findings and directions for future research were discussed.

APA, Harvard, Vancouver, ISO, and other styles

23

Clark, Terryann C., Jude Ball, John Fenaughty, Bradley Drayton, Theresa (Terry) Fleming, Claudia Rivera-Rodriguez, Jade Le Grice, et al. "Indigenous adolescent health in Aotearoa New Zealand: Trends, policy and advancing equity for rangatahi Maori, 2001–2019." Lancet Regional Health - Western Pacific 28 (November 2022): 100554. http://dx.doi.org/10.1016/j.lanwpc.2022.100554.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Thompson, Stephanie G., P. Alan Barber, John H. Gommans, Dominique A. Cadilhac, Alan Davis, John N. Fink, Matire Harwood, et al. "The impact of ethnicity on stroke care access and patient outcomes: a New Zealand nationwide observational study." Lancet Regional Health - Western Pacific 20 (March 2022): 100358. http://dx.doi.org/10.1016/j.lanwpc.2021.100358.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

SHAH, AJIT. "The influence of exclusion criteria on the relationship between suicide rates and age in cross-national studies." International Psychogeriatrics 19, no. 5 (June 13, 2007): 989–92. http://dx.doi.org/10.1017/s1041610207005613.

Full text

Abstract:

Traditionally, suicide rates increase with aging in many countries (Shah and De, 1998). However, exceptions to this observation are emerging. Data from the World Health Organization (WHO) in 1995 revealed that female suicide rates did not increase with age in Mauritius, Colombia, Albania and Finland (Shah and De, 1998). Suicide rates increased with age in Switzerland (Ajdacic-Gross et al., 2006), Brazil (Mello-Santos et al., 2005) and China (Yip et al., 2000), but there were smaller peaks in the younger age-bands. Suicide rates among Australian, New Zealand and white American males increased with age, but suicide rates for females initially increased with age, peaking at menopause, and declining thereafter (Skegg and Cox, 1991; Woodbury et al., 1988; Snowdon and Snowdon, 1995). Suicide rates among non-white Americans (Seiden, 1981; Woodbury et al., 1988), Indians (Adityanjee, 1986; Bhatia et al., 1987), Jordanians (Daradekh, 1989), Indian immigrants to the U.K. (Raleigh et al., 1990; Needleman et al., 1997) and some east European countries (Sartorius, 1995) declined with increasing age.

APA, Harvard, Vancouver, ISO, and other styles

26

Boden, J., S. Hetrick, N. Bowden, S. Fortune, L. Marek, R. Theodore, T. Ruhe, J. Kokaua, and M. Hobbs. "Empowering community control over alcohol availability as a suicide and self-harm prevention measure: Policy opportunity in Aotearoa New Zealand." Lancet Regional Health - Western Pacific 29 (December 2022): 100631. http://dx.doi.org/10.1016/j.lanwpc.2022.100631.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

WEATHERALL, M. "Geriatric evaluation and management in a New Zealand hospital." Australian and New Zealand Journal of Medicine 30, no. 1 (February 2000): 101. http://dx.doi.org/10.1111/j.1445-5994.2000.tb01072.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Beaglehole, Ben, Giles Newton-Howes, and Chris Frampton. "Compulsory Community Treatment Orders in New Zealand and the provision of care: An examination of national databases and predictors of outcome." Lancet Regional Health - Western Pacific 17 (December 2021): 100275. http://dx.doi.org/10.1016/j.lanwpc.2021.100275.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Law, Alice, and Matthew Croucher. "Prescribing trends and safety of clozapine in an older persons mental health population." International Psychogeriatrics 31, no. 12 (March 21, 2019): 1823–29. http://dx.doi.org/10.1017/s1041610219000255.

Full text

Abstract:

ABSTRACTObjectives:To provide additional data concerning the safety, effectiveness and local prescribing trends of clozapine in elderly patients.Design:Retrospective observational case-series analysis.Setting:Data were collected from the medical files of 167 patients prescribed clozapine.Participants:All patients prescribed clozapine in the last 15 years by the psychogeriatric service in Christchurch, New Zealand. The subjects were mostly aged over 65; however, patients under 65 are also accepted into the service on a case by case basis if they have an age-related health condition.Results:Twenty-five (15.0%) patients had their clozapine stopped due to a significant adverse reaction, including eleven who developed significant neutropenia. Seventy-four (44.3%) of the patients had no recorded side effects at all. Sixty-five (38.9%) of our elderly patients died while taking clozapine, though none of these deaths was felt to be related to clozapine use. Several patients safely initiated clozapine in either their own home or a nursing home without requiring hospital admission. Only two patients ceased clozapine due to ineffectiveness, and one hundred, forty-two (86.1%) of the patients had positive comments in their medical record regarding the benefits of clozapine for their particular case.Conclusions:We found clozapine could be used safely and effectively in our patient group, for a wider range of indications and at lower doses than younger patients. Data collection regarding cause of death in elderly patients who were ever prescribed clozapine was problematic, and more research into this area is required.

APA, Harvard, Vancouver, ISO, and other styles

30

Suh, Guk-Hee, Anders Wimo, Serge Gauthier, Daniel O'Connor, Manabu Ikeda, Akira Homma, Jacqueline Dominguez, and Bong-Min Yang. "International price comparisons of Alzheimer's drugs: a way to close the affordability gap." International Psychogeriatrics 21, no. 6 (September 8, 2009): 1116–26. http://dx.doi.org/10.1017/s104161020999086x.

Full text

Abstract:

ABSTRACTBackground: Alzheimer's drugs are believed to have limited availability and to be unaffordable in low- and middle-income countries compared to high-income countries. The price, availability and affordability of Alzheimer's drugs have not been reported before.Methods: During 2007 an international survey was conducted in 21 countries in six continents (Argentina, Australia, Brazil, the Dominican Republic, France, India, Japan, Macedonia, Mexico, New Zealand, Nigeria, the Philippines, Portugal, Serbia, South Korea, Switzerland, Taiwan, Thailand, Uganda, the U.K. and the U.S.A.). Prices of Alzheimer's drugs were compared using the affordability index (the total number of units purchasable with one's daily income) derived from purchasing power parity (PPP) converted prices as well as raw prices.Results: Donepezil is available in all 21 countries, whereas the newer drugs are less available. A 5 mg tablet of branded originator donepezil costs just US$0.26 in India and US$0.31 in Mexico, whereas it costs US$6.64 in the U.S.A. Pricing conditions of rivastigmine, galantamine and memantine appear to be similar to that of donepezil. The cheapest branded originators are from India and Mexico. However, in terms of PPP, Alzheimer's drugs in other low- and middle-income countries are much more expensive than in high-income countries. Most people in low- and middle-income countries cannot afford Alzheimer's drugs.Conclusions: Alzheimer's drugs, albeit available, are often unaffordable for those who need them most. It is hoped that equitable differential pricing will be applied to Alzheimer's drugs.

APA, Harvard, Vancouver, ISO, and other styles

31

Wu, Frederick Y., and William M. McDonald. "Neuroimaging in geriatric psychiatry: New developments." Current Psychosis and Therapeutics Reports 2, no. 1 (March 2004): 37–41. http://dx.doi.org/10.1007/s11922-004-0006-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Brewer, Naomi, Sunia Foliaki, Michelle Gray, John D. Potter, and Jeroen Douwes. "Pasifika women's knowledge and perceptions of cervical-cancer screening and the implementation of self-testing in Aotearoa New Zealand: A qualitative study." Lancet Regional Health - Western Pacific 28 (November 2022): 100551. http://dx.doi.org/10.1016/j.lanwpc.2022.100551.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Brinded, Philip M. J. "Forensic Psychiatry in New Zealand." International Journal of Law and Psychiatry 23, no. 5-6 (September 2000): 453–65. http://dx.doi.org/10.1016/s0160-2527(00)00053-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Barak, Yoram, Andrew R. Gray, Charlene Rapsey, and Kate Scott. "The Dunedin dementia risk awareness project: pilot study in older adults." International Psychogeriatrics 32, no. 2 (September 13, 2019): 241–54. http://dx.doi.org/10.1017/s1041610219000772.

Full text

Abstract:

ABSTRACTAims:The USA and UK governmental and academic agencies suggest that up to 35% of dementia cases are preventable. We canvassed dementia risk and protective factor awareness among New Zealand older adults to inform the design of a larger survey.Method:The modified Lifestyle for Brain Health scale quantifying dementia risk was introduced to a sample of 304 eligible self-selected participants.Results:Two hundred and sixteen older adults (≥50 years), with mean ± standard deviation age 65.5 ± 11.4 years (50–93 years), completed the survey (71% response rate). Respondents were mostly women (n = 172, 80%), European (n = 207, 96%), and well educated (n = 100, 46%, with a tertiary qualification; including n = 17, 8%, with a postgraduate qualification). Around half of the participants felt that they were at a future risk of living with dementia (n = 101, 47%), and the majority felt that this would change their lives significantly (n = 205, 95%), that lifestyle changes would reduce their risk (n = 197, 91%), and that they could make the necessary changes (n = 189, 88%) and wished to start changes soon (n = 160, 74%). Only 4 of 14 modifiable risk or protective factors for dementia were adequately identified by the participants: physical exercise (81%), depression (76%), brain exercises (75%), and social isolation (83%). Social isolation was the commonly cited risk factor for dementia, while physical exercise was the commonly cited protective factor. Three clusters of brain health literacy were identified: psychosocial, medical, and modifiable.Conclusion:The older adults in our study are not adequately knowledgeable about dementia risk and protective factors. However, they report optimism about modifying risks through lifestyle interventions.

APA, Harvard, Vancouver, ISO, and other styles

35

Minhinnick, Alice, Phyu Sin Aye, J. Mark Elwood, and Mark James McKeage. "Cancer of the nasopharynx in Aotearoa New Zealand from 1994 to 2018: Incidence and survival in a population-based, national registry cohort study." Lancet Regional Health - Western Pacific 24 (July 2022): 100522. http://dx.doi.org/10.1016/j.lanwpc.2022.100522.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Chenoweth, Lynn, Ian Forbes, Richard Fleming, Madeleine T. King, Jane Stein-Parbury, Georgina Luscombe, Patricia Kenny, Yun-Hee Jeon, Marion Haas, and Henry Brodaty. "PerCEN: a cluster randomized controlled trial of person-centered residential care and environment for people with dementia." International Psychogeriatrics 26, no. 7 (March 26, 2014): 1147–60. http://dx.doi.org/10.1017/s1041610214000398.

Full text

Abstract:

ABSTRACTBackground:There is good evidence of the positive effects of person-centered care (PCC) on agitation in dementia. We hypothesized that a person-centered environment (PCE) would achieve similar outcomes by focusing on positive environmental stimuli, and that there would be enhanced outcomes by combining PCC and PCE.Methods:38 Australian residential aged care homes with scope for improvement in both PCC and PCE were stratified, then randomized to one of four intervention groups: (1) PCC; (2) PCE; (3) PCC +PCE; (4) no intervention. People with dementia, over 60 years of age and consented were eligible. Co-outcomes assessed pre and four months post-intervention and at 8 months follow-up were resident agitation, emotional responses in care, quality of life and depression, and care interaction quality.Results:From 38 homes randomized, 601 people with dementia were recruited. At follow-up the mean change for quality of life and agitation was significantly different for PCE (p = 0.02, p = 0.05, respectively) and PCC (p = 0.0003, p = 0.002 respectively), compared with the non-intervention group (p = 0.48, p = 0.93 respectively). Quality of life improved non-significantly for PCC+PCE (p = 0.08), but not for agitation (p = 0.37). Improvements in care interaction quality (p = 0.006) and in emotional responses to care (p = 0.01) in PCC+PCE were not observed in the other groups. Depression scores did not change in any of the groups. Intervention compliance for PCC was 59%, for PCE 54% and for PCC+PCE 66%.Conclusion:The hypothesis that PCC+PCE would improve quality of life and agitation even further was not supported, even though there were improvements in the quality of care interactions and resident emotional responses to care for some of this group. The Australian New Zealand Clinical Trials Registry Number is ACTRN 12608000095369.

APA, Harvard, Vancouver, ISO, and other styles

37

Joyce, Peter R. "Focus on psychiatry in New Zealand." British Journal of Psychiatry 180, no. 5 (May 2002): 468–70. http://dx.doi.org/10.1192/bjp.180.5.468.

Full text

Abstract:

New Zealand has been inhabited by the indigenous Maori people for more than 1000 years. The first European (Pakeha) to see the country, in 1642, was the Dutch explorer Abel Tasman. But the English explorer James Cook, who landed there in 1769, was responsible for New Zealand becoming part of the British Empire and, later, the British Commonwealth. In 1840 the Treaty of Waitangi was signed between Maori leaders and Lieutenant-Governor Hobson on behalf of the British Government. The three articles of the Treaty gave powers of Sovereignty to the Queen of England; guaranteed to the Maori Chiefs and tribes full, exclusive and undisturbed possession of their lands, estates, forests and fisheries; and extended to the Maori people Royal protection and all the rights and privileges of British subjects.

APA, Harvard, Vancouver, ISO, and other styles

38

Hall, A. "‘Bush psychiatry’ in Westland New Zealand." Australian and New Zealand Journal of Psychiatry 34, s1 (January 2000): A27—A28. http://dx.doi.org/10.1080/000486700625.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Simpson, Alexander I. F., and D. G. Chaplow. "Forensic Psychiatry Services in New Zealand." Psychiatric Services 52, no. 7 (July 2001): 973—a—974. http://dx.doi.org/10.1176/appi.ps.52.7.973-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Bale, Rod. "An experience of New Zealand psychiatry." Psychiatric Bulletin 26, no. 5 (May 2002): 192–93. http://dx.doi.org/10.1192/pb.26.5.192.

Full text

Abstract:

New Zealand, an outstandingly beautiful country, offers an opportunity for the psychiatrist from the UK to work in an alternative environment. There is currently a shortage of trained psychiatrists to fill the available posts. The experience of a locum consultant post in adult mental health in the Nelson Marlborough Mental Health Service at the top of the South Island, at the beginning of the new millennium, forms the basis of observations made in this article, the purpose of which is to describe points of interest in the similarities and differences in psychiatric practice between the UK and New Zealand.

APA, Harvard, Vancouver, ISO, and other styles

41

Neferu, Ramona, and Han Yan. "The nature of geriatrics." University of Western Ontario Medical Journal 84, no. 2 (March 3, 2016): 29–30. http://dx.doi.org/10.5206/uwomj.v84i2.4302.

Full text

Abstract:

Dr Michael Borrie is the Program Director of the South Western Ontario Regional Geriatric Program and past Chair of the Division of Geriatric Medicine. Trained in New Zealand and Canada, Dr Borrie shared with us his experiences from 30 years of practice in geriatric medicine and his current roles as a clinician, researcher, administrator, and teacher.

APA, Harvard, Vancouver, ISO, and other styles

42

MARTIN, RONALD L. "Geriatric psychiatry. What's new about the old. Introduction." Psychiatric Clinics of North America 20, no. 1 (March 1997): xi—xiii. http://dx.doi.org/10.1016/s0193-953x(05)70388-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Rosack, Jim. "Geriatric Psychiatry Journal Gets New Editor in Chief." Psychiatric News 36, no. 10 (May 18, 2001): 10. http://dx.doi.org/10.1176/pn.36.10.0010a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Timney, Brian. "A New Zealand experience." Psychiatric Bulletin 15, no. 11 (November 1991): 679–80. http://dx.doi.org/10.1192/pb.15.11.679.

Full text

Abstract:

Hamilton is New Zealand's fourth largest city. Situated on the banks of the Waikato river in the central North Island, it was my home during a year's experience as a psychiatric registrar in the Waikato Hospital. This paper describes aspects of a medical and psychiatric practice, including training in New Zealand, and offers general advice to trainees planning or considering overseas placements.

APA, Harvard, Vancouver, ISO, and other styles

45

Shulman, Richard, Reenu Arora, Amna Ali, and Judith Versloot. "The 12 Ds of geriatric medical-psychiatry: A new format for geriatric case presentation." MedEdPublish 12 (June 28, 2022): 46. http://dx.doi.org/10.12688/mep.19169.1.

Full text

Abstract:

Background: We present a new format for geriatric case presentation called the 12 Ds of Geriatric Medical-Psychiatry that facilitates an integrated discussion of both the physical and mental health issues that pertain to any geriatric patient. The format can be used to replace or to complement traditional medical model case presentation and can also be used as a teaching aid to provide the parameters for a holistic view of the geriatric patient. Methods: We developed the 12 Ds of Geriatric Medical-Psychiatry for case presentation by modifying the SBAR (situation, background, assessment, recommendations) with 12 clinical considerations that apply to any geriatric patient. Following implementation of the 12 Ds of Geriatric Medical-Psychiatry case presentation in our integrated team of geriatric medicine and psychiatry healthcare providers, we successfully used the 12 Ds model to present more than 180 patients and found the model easy to use and well received by learners and colleagues. Conclusion: The 12 Ds of Geriatric Medical-Psychiatry provides a comprehensive format to discuss the pertinent issues facing geriatric patients. When used in an SBAR format, it appears to be an efficient means for integrated case presentation and/or can be used as a tool for teaching and understanding a holistic view of complex geriatric cases.

APA, Harvard, Vancouver, ISO, and other styles

46

Pu, Lihui, Wendy Moyle, Cindy Jones, and Michael Todorovic. "468 - Can a Robotic Seal Called PARO Manage Chronic Pain in People with Dementia Living in Nursing Homes?" International Psychogeriatrics 32, S1 (October 2020): 190. http://dx.doi.org/10.1017/s1041610220003208.

Full text

Abstract:

AbstractObjective: To evaluate the effect of interaction with a robotic seal (PARO) for pain management in nursing home residents living with dementia.Methods: Registered with the Australian New Zealand Clinical Trials Registry (ACTRN 12618000082202), a pilot randomized controlled trial followed by semi-structured interviews were conducted between January 2018 and January 2019. Forty-three residents aged ?65 years living with dementia and chronic pain were recruited from three nursing homes in Australia. Participants were randomized to either a PARO group (individual, non-facilitated, 30-minute sessions, five days per week for six weeks) or a usual care group using a computer-generated random number. Observational pain behaviors were rated by researchers using the Pain Assessment in Advanced Dementia (PAINAD) scale and staff-rated pain levels were measured by the numeric rating scale. Medications regularly prescribed and as needed were quantified by the Medication Quantification Scale-III (MQS-III). Generalized estimating equation model and thematic analysis were used to analyze the data.Results: Participants in the PARO group had significantly lowered level of observed pain (-0.514, 95% confidence interval [CI] -0.774 to -0.254, p<0.001) and used fewer PRN medications (-1.175, 95% CI - 2.205 to -0.145, p=0.025) than those in usual care after controlling for age, gender, cognitive function and medications at baseline. There were no significant differences in staff-rated pain levels and regularly scheduled medications between the two groups. Interviews also indicated that the PARO intervention may reduce the pain experience through distraction and reminiscence of previous positive memories. Limitations of weight, voice and characteristics of PARO were identified.Conclusions and Implications: PARO shows promise in reducing pain and medications for nursing home residents living with dementia and chronic pain. This intervention might be incorporated into daily practice as an alternative to manage pain in people with dementia. Care staff need to balance the benefits and limitations of incorporating social robots into their clinical practice and residents’ individualized preferences need to be considered. Larger randomized controlled trials with longer time frames are warranted to further test the use of PARO in long-term care settings.

APA, Harvard, Vancouver, ISO, and other styles

47

Aarsland, Dag, and Uwe Ehrt. "Basal ganglia diseases and geriatric psychiatry: a new approach." Current Opinion in Psychiatry 16, no. 6 (November 2003): 621–27. http://dx.doi.org/10.1097/00001504-200311000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Marksteiner, Josef, Christian Jagsch, Georg Psota, Michael Rainer, Beatrix Ruepp, Evelin Singewald, Matthäus Fellinger, and Johannes Wancata. "Geriatric psychiatry in Austria: Current status and new perspectives." Geriatric Mental Health Care 1, no. 4 (December 2013): 82–87. http://dx.doi.org/10.1016/j.gmhc.2013.10.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Sukolski, Mike. "Retaining Psychiatrists in New Zealand." Australasian Psychiatry 13, no. 3 (September 2005): 310–11. http://dx.doi.org/10.1080/j.1440-1665.2005.2208_1.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Disley, Barbara, and Carolyn Coggan. "Youth Suicide in New Zealand." Crisis 17, no. 3 (May 1996): 116–22. http://dx.doi.org/10.1027/0227-5910.17.3.116.

Full text

Abstract:

It is increasingly acknowledged that suicidal behavior has a considerable impact on both individuals and society in terms of acute physical and mental health problems, long-term disability, and death, as well as quality of life and resource provision. In recent years there has been increasing concern about youth suicide rates. The escalation in suicide rates among individuals in the 15-24-year age group began around 1980 and has continued to rise. While this trend is evident in most OECD countries, the increase in New Zealand has been more substantial and sustained than in other countries. This article examines the occurrence of youth suicide in New Zealand. Next, an outline of New Zealand government and nongovernmental responses to youth suicide are presented. Finally, a variety of intervention options which take into account New Zealand societal conditions are outlined.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!